Toll-like receptor 9 agonists up-regulates the expression of cyclooxygenase-2 via activation of NF-kappaB in prostate cancer cells

Mol Biol Rep. 2010 Apr;37(4):1849-55. doi: 10.1007/s11033-009-9620-5. Epub 2009 Jul 19.

Abstract

CpG-oligonucleotides (CpG-ODNs), mimicking bacterial DNA, have recently been shown to stimulate prostate cancer invasion in vitro via Toll-like receptor 9 (TLR9). Since cyclooxygenase 2 (COX-2), frequently overexpressed in multiple tumor types including prostate cancer, is a causal factor for tumor development, invasion and metastasis, an interesting question is raised whether TLR9 regulates COX-2 expression in prostate cancer cells. To address this question, herein we examined COX-2 expression in PC-3 cells stimulated with different doses and time courses of CpG-ODNs. The regulatory role of NF-kappaB in TLR9-mediated COX-2 expression was also investigated. CpG-ODN was found to up-regulate the expression of COX-2 in PC-3 cells in a dose- and time-dependent manner, but have little impact on COX-1 expression. Moreover, CpG-ODN also promoted nuclear translocation and activation of NF-kappaB, which appeared to be required for COX-2 induction by CpG-ODN. Overall, TLR9 up-regulates COX-2 expression in prostate cancer cells, at least partially through the activation of NF-kappaB, which may be implicated in tumor invasion and metastasis.

MeSH terms

  • Cell Line, Tumor
  • Cell Nucleus / drug effects
  • Cell Nucleus / metabolism
  • Chloroquine / pharmacology
  • Cyclooxygenase 1 / genetics
  • Cyclooxygenase 1 / metabolism
  • Cyclooxygenase 2 / biosynthesis
  • Cyclooxygenase 2 / genetics*
  • Dose-Response Relationship, Drug
  • Enzyme Induction / drug effects
  • Gene Expression Regulation, Neoplastic / drug effects
  • Humans
  • Male
  • NF-kappa B / metabolism*
  • Oligodeoxyribonucleotides / pharmacology*
  • Prostatic Neoplasms / enzymology*
  • Prostatic Neoplasms / genetics*
  • Protein Transport / drug effects
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Time Factors
  • Toll-Like Receptor 9 / agonists*
  • Up-Regulation / drug effects*

Substances

  • CPG-oligonucleotide
  • NF-kappa B
  • Oligodeoxyribonucleotides
  • RNA, Messenger
  • TLR9 protein, human
  • Toll-Like Receptor 9
  • Chloroquine
  • Cyclooxygenase 1
  • Cyclooxygenase 2
  • PTGS1 protein, human
  • PTGS2 protein, human